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Abstract The objective of this work was to study the
effect of nocturnal intermittent hypoxia on auditory func-
tion of simple snoring patients and subjects affected by
OSAS; we compared the audiologic profile with the
severity of OSAS to detect early signs of cochlear damage.
One hundred-sixty patients underwent overnight
polysomnography, micro-otoscopy, multi-frequency
audiometry, acufenometry, TEOAE recording and d-ROMs
test. All subjects were divided in four groups, based on
presence/absence of AHI (simple snoring without OSAS,
mild OSAS, moderate OSAS, severe OSAS). Sixty
(37.5 %) patients were not affected by OSAS, 58
(36.25 %) presented a mild OSAS, 18 (11.25 %) a mod-
erate OSAS and 24 (15 %) a severe OSAS; the 57.14 % of
moderate to severe OSAS suffered from tinnitus with
respect to the 31.03 % of mild OSAS (P = 0.024). A
higher percentage (41.66 %) of hearing loss was found
among individuals with moderate to severe degree of
OSAS (P\ 0.0001). All groups were characterized by a
mean hearing threshold\25 dB HL for 0.25–3 kHz fre-
quencies and a progressive decrease in hearing sensitivity,
particularly for 6–16 kHz frequencies (P\ 0.05). The
analysis of otoacoustic emissions SNR mean values
evidenced a significant difference between simple snoring
and severe OSAS individuals for 3 and 4 kHz frequencies
(P\ 0.05). d-ROM levels resulted higher in patients with
severe OSAS with respect to simple snoring subjects
(P = 0.004). Our data underline the key role of chronic
nocturnal intermittent hypoxia in the development of an
early cochlear damage and a more marked high-frequency
hearing loss in case of severe OSAS (P\ 0.05).
Keywords OSAS  Hearing loss  Tinnitus  Multi-
frequency audiometry  TEOAE
Introduction
Affecting C4 % of men and 2 % of women, obstructive
sleep apnea syndrome (OSAS) is a condition characterized
by intermittent obstruction of the upper airways with
consequent repetitive episodes of apnea and/or hypopnea,
desaturations and an altered sleep pattern. With respect to
the general population, patients with OSAS often suffer
from daytime sleepiness, morning headache, reduced
memory and concentration capacity, endocrine and meta-
bolic derangements; the presence of OSAS is considered an
independent predictor for cardiovascular pathologies like
hypertension, coronary artery disease and stroke [1–3].
The repeated episodes of hypoxia and normoxia are con-
sidered themain factors influencing the production of reactive
oxygen species (ROS) and the promotion of oxidative stress,
endothelial dysregulation, activation and propagation of
inflammatory cascades with vascular dysfunction, reduced
basal and functional capillarity rarefaction with an additional
risk of impaired peripheral perfusion [4, 5].
Therefore, OSAS may lead to cerebral vascular insuf-
ficiency resulting in hypoxia, acute hemodynamic change,
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decreased cerebral blood flow during episodes of apnea and
ischemic injury to the cochlea [6–10]. Both inner ear and
acoustic nerve are highly dependent on the oxygen supply;
specifically the cochlea is sensitive to circulatory alter-
ations because of its single terminal artery supply and
insufficient collateral circulation [11].
Several reports investigated the relation between sleep
disorders and auditory dysfunction, recognizing in OSAS
patients a higher risk of impairment of neuronal and vas-
cular function of the auditory pathway. Specifically,
Muchnik et al. studying the auditory brainstem responses
(ABR) of 79 OSAS individuals, evidenced a prolonged
transmission time between waves I and III and I and V in
the moderate and severe OSAS subgroups with respect to
healthy subjects [12]. Kotterba et al. analyzing data relative
to 20 patients affected by severe OSAS, found prolonga-
tions of wave latency I ( P B 0.001) and interpeak latency
I–V (P B 0.001) in the 60 % of the total sample, with 9
(45 %) subjects characterized by pontomesencephal lesions
[13]. The auditory pathway sensitiveness to reduced oxy-
gen levels was also investigated by Atis¸ et al. who recorded
the ABR of 21 patients with severe chronic obstructive
pulmonary disease, with the 76.1 % of the sample showing
ABR abnormalities like prolonged wave I peak latencies
(42.8 %), wave V peak latencies (38.1 %) and III–V
interpeak latencies (38.1 %) [14]. Recently Casale et al.
comparing audiological data of 18 patients with severe
OSAS and 21 simple snoring subjects, evidenced pro-
longed mean latencies of waves I, III, V (P\ 0.05) and a
significantly (P\ 0.01) higher pure-tone audiometry
(PTA) in OSAS group with respect to healthy people [15].
Basing on these instrumental evidences, purpose of our
work was to study the effect of chronic nocturnal inter-
mittent hypoxia on auditory function of simple snoring
patients and subjects with various degrees of OSAS; we
compared also their audiologic profile with the severity of
OSAS to detect early signs of cochlear damage.
Materials and methods
One hundred and seventy-two snoring patients (107 males
and 65 females), ranging 38–55 years of age, were exam-
ined from January 2012 to June 2014 at the Hearing Sec-
tion of the Department of Bio-technology of Palermo
University. Individuals with any middle or inner ear
pathology (e.g., cranio-facial abnormality, syndromes
associated to hearing loss, otosclerosis, acoustic neuroma,
chronic otitis, previous myringotomy, VT insertion or
tympanoplasty) or medical diseases which affect or are
suspected to affect hearing (e.g., diabetes mellitus,
untreated hypertension, noise exposure, hypercholes-
terolemia, history of ototoxic drugs administration) or
coexisting psychiatric disorders were excluded from this
study.
Each patient enrolled in our study underwent an over-
night polysomnography (PSG) for suspected OSAS, a
physical examination of the ears through micro-otoscopy, a
complete audiologic evaluation and d-ROMs test.
The study protocol was completely explained to
patients and written informed consent was obtained from
each subject. The study design was approved by the
Palermo University Human Research Ethics Committee.
Twelve patients were excluded from the study because
of cranio-facial abnormality (1 case), history of ototoxic
drugs administration (5 cases), otosclerosis (2 cases),
chronic otitis (3 cases) and previous tympanoplasty (1
case); 160 subjects were enrolled and divided in four
groups, based on presence/absence of AHI (apnea ? hy-
popnea per hour of sleep) and according to international
guidelines [16]: (1) simple snoring without OSAS; (2) mild
OSAS; (3) moderate OSAS; (4) severe OSAS.
Diagnosis of OSAS was made through modified portable
sleep apnea monitoring through a polygraphy Mesam-8
Polymesam, with recording of abdominal and chest
movements, body position, snoring, oxygen blood satura-
tion, pulse rate, oro-nasal airflow (nasal air pressure).
According to international guidelines, an AHI\5 was
considered suggestive of simple snoring without OSAS;
OSAS was classified in ‘‘mild’’ (5\AHI\ 15), ‘‘moder-
ate’’ (15\AHI\ 30) and ‘‘severe’’ (AHI[30) [16].
Audiological assessment was performed by multi-fre-
quency audiometry (considering the frequencies
0.25–0.5–1–2–3–4–6–8–9–10–11.2–12.5–14–16 kHz),
tympanometry with stapedius reflex and Transient-evoked
otoacoustic emissions (TEOAE diagnostic) for each ear.
Audiometric threshold was considered as the pure tone
average (PTA) for the frequencies 0.5–1–2–4 kHz and
divided in: normal hearing (\20 dB); mild hearing loss
(21–40 dB); moderate hearing loss (41–70 dB); severe
hearing loss (71–90 dB); profound hearing loss ([90 dB).
Acufenometry included pitch masking (matching the
frequency of the tinnitus with a variety of stimuli) and
loudness matching (estimating the loudness of tinnitus with
a pure tone or noise); the difference between the hearing
threshold and the sensation level was considered tinnitus
loudness (0–5 dB, 5, 10, 15,[15 dB above the hearing
threshold) [17–20].
TEOAE measurements were evaluated in reproducibil-
ity (expressed as the correlation between two waveforms,
namely for responses stored in buffers A and B, acquired
alternately) and were recorded by using as ‘‘PASS’’ criteria
a signal-to-noise ratio (SNR) C6 dB in four of five 1/2
octave frequency bands at 1, 1.5, 2, 3, and 4 kHz. The tool
used was the ‘SENTIERO by Path Medical GmbH’, that is
based on the nonlinear cross-correlation method (ILO88) of
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TEOAE recording. The TEOAE diagnostic was conducted
by placing a small probe tip from the ‘Path Medi-
cal’(3.9 mm diameter 9 11.7 mm) inside the patient’s ear
canal; when powered on, the instrument initiated a routine
self-calibration before recordings were made. The click
rate was approximately 97 per second and each stimulus (at
the probe loudspeaker output) consisted of a single 80 ls
square pulse. To eliminate passive mechanical artifacts
from the recorded waveform, stimuli were presented in
blocks of four stimuli: three small positive polarity stimuli
followed by one big negative polarity stimulus three times
as large. Click peak stimulus level was 80 dB SPL.
Emissions elicited from the outer hair cells in response to
the clicks were picked up by the internal microphone of the
equipment and were windowed and filtered to remove
unwanted signals; all response data outside a window from
5 to 13 mS, after the stimulus, were removed to eliminate
the stimulus signal.
Reactive oxygen metabolites (ROMs) levels were
measured in serum samples by the Diacron reactive oxygen
metabolites (d-ROM) test. It is based on the reaction of
hydroperoxides of a biological sample with transition
metals (iron) that catalyze the formation of free radicals
which then oxidize an alchilamine forming a colored rad-
ical detected by photometry at 505 nm.
Ten mL of blood is mixed with 1 ml of an acidic (PH 4.8)
buffer reagent (R2) in order to release iron from plasma
proteins that will react with peroxides of the blood to form
free radicals, and then 10 mL of a chromogen reagent (R1
reagent, alchilamine) are added forming a pink-colored
derivative. This colored derivative is photometrically
quantified and the optical density is directly proportional to
the concentration of ROMs [21]. Reference values of
d-ROMs test are between 250 and 300 Carratelli Units
(CARR U), independently of gender and age; values higher
than 300 CARR U indicate, after a border-line bracket
(301–320 CARR U), progressively increasing levels of
oxidative stress: 321–340 CARR U—low level oxidative
stress; 341–400 CARR U—middle level of oxidative stress;
401—500 CARR U High level of oxidative stress;[500
CARR U Very high level of oxidative stress [22].
Statistical analysis was conducted with Matlab com-
puter programme; v2 test, odds ratio (OR) and/or exact test
of Fisher test were used, following usual conditions of
application. Significance was set at 0.05.
Result
A total of 160 subjects were analysed; 103 (64.37 %) were
males and 57 (35.63 %) were females with a male/female
ratio of 1.8. The age of patients ranged from 38 to 55 years,
with a mean age of 46.19 ± 7.01 years.
Table 1 shows the presence/absence and degree of
OSAS among the subjects included in the study: 60
(37.5 %) patients were not affected by OSAS, 58
(36.25 %) presented a mild OSAS, 18 (11.25 %) a mod-
erate OSAS and 24 (15 %) a severe OSAS. A statistical
significant difference in the severity of OSAS was evi-
denced among the sex, with a higher percentage of males
suffering from severe OSAS (P = 0.01). In fact the
20.38 % (21/103) of males had a AHI value[30 with
respect to the 5.26 % (3/57) of females.
The 33.75 % (54/160) of patients were affected by tin-
nitus, without significant difference among the sex; 42
subjects (42 %) with and 12 (20 %) without OSAS repor-
ted tinnitus (P = 0.004); an association between degree of
OSAS and tinnitus prevalence was evidenced, with the
57.14 % of cases of moderate to severe OSAS suffering
from tinnitus with respect to the 31.03 % of mild OSAS
(P = 0.024). In the majority of cases tinnitus pitch was
matched to tones in the 4000–8000 Hz range (64.81 %),
but no significant difference between subjects with various
degree of OSAS was found.
Audiological assessment of the total cohort revealed a
normal hearing, a mild and a moderate hearing loss in the
70.94 % (227/320 ears), the 25.93 % (83/320 ears) and the
3.12 % (10/320 ears) of cases respectively; a slight
Table 1 Audiologic characteristics, mean PTA and d-ROM test of the cohort
GROUP Patients
N (%)
Tinnitus
N (%)
Normal hearing
N (%)*
Hearing loss
N (%)*
PTA0.25–8 kHz (dB
HL)
PTA9-16 kHz (dB
HL)
d-ROM test
(CARR U)
No OSAS 60 (37.5) 12 (20) 87/120 (72.5) 33/120 (27.5) 21.42 36.6 309.45 ± 43.11
Mild OSAS 58 (36.25) 18 (31.03) 91/116 (78.45) 25/116 (21.55) 23.25 46.38 314.36 ± 53.05
Moderate
OSAS
18 (11.25) 9 (50) 20/36 (55.56) 16/36 (44.44) 27.05 64.97 314.05 ± 39.2
Severe
OSAS
24 (15) 15 (62.5) 29/48 (60.42) 19/48 (39.58) 26.83 67.43 363.33 ± 70.58
Total 160 (100) 54 (33.75) 227/320 (70.94) 93/320 (29.06) 23.52 47.77 323.29 ± 56.87
* Calculated on the total ears
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difference in the prevalence of hearing loss was evidenced
between patients with (30 %) and without (27.5 %) OSAS
(P = 0.23). Specifically a higher percentage (41.66 %) of
hearing loss was found among individual with a moderate
to severe degree of OSAS (P\ 0.0001). All subjects
affected by moderate sensorineural hearing loss referred
subjective tinnitus (P\ 0.001).
Figure 1 depicts the average multi-frequency audiome-
try thresholds levels according to the presence/absence and
degree of OSAS. It is well shown that all groups were
characterized by a mean hearing threshold\25 dB HL for
0.25–0.5–1–2–3 kHz frequencies and a progressive
decrease in hearing sensitivity, with a peak[60 dB HL for
11.2–12.5–14–16 kHz frequencies in case of moderate to
severe OSAS. In fact, the audiograms relative to subjects
with AHI[15 were represented by ‘‘sky-fall’’ curves,
differently from mild OSAS group, characterized by a
high-frequency ‘‘gently sloping’’ audiogram. From the
comparison of the mean hearing thresholds, a statistical
significant difference was evidenced between severe and
mild OSAS groups for 6–8–9–10–11.2–12.5–14–16 kHz
frequencies (P\ 0.05).
The 45 % (27/60) of simple snoring and the 24 % (24/
100) of OSAS patients passed the TEOAEs recording
(P\ 0.05). Specifically SNR mean values (Fig. 2), calcu-
lated for each ear, were respectively of 8.28 ± 4.56
(1 kHz), 12.60 ± 5.66 (1.5 kHz), 10.12 ± 6.38 (2 kHz),
3.85 ± 3.76 (3 kHz) and 2.39 ± 2.78 (4 kHz) in patients
with OSAS and of 7.46 ± 5.19 (1 kHz), 12.16 ± 6.90
(1.5 kHz), 9.58 ± 6.40 (2 kHz), 5.00 ± 4.93 (3 kHz) and
3.76 ± 4.37 (4 kHz) in no OSAS subjects; a significant
difference was found only between simple snoring and
severe OSAS individuals for 3 and 4 kHz frequencies
(P\ 0.05).
The analysis of ROM levels (Table 1), measured using
the d-ROM test, showed a mean value of 323.29 ± 56.87
CARR U for the total cohort with a significant difference
(P = 0.004) between patients with severe OSAS
(363.33 ± 70.58 CARR U) and simple snoring subjects
(309.45 ± 43.11 CARR U); additionally a higher mean
ROM level (341.11 ± 59.53 CARR U) was observed in
individuals suffering from tinnitus (P = 0.035).
Discussion
The adverse consequences of decreased cerebral blood flow
during episodes of apnea were previously studied; the inner
ear represents an anatomical location extremely susceptible
to hypoxic/anoxic injury due to the formation of ROS and
increased oxidative stress, which in turn activate inflam-
matory and immune responses leading to vascular and
metabolic complications [23–25]. Particularly the cochlear
outer hair cells of the basal turn suffer from the free-radical
damage, probably because of their significant lower
activity of glutathione-related antioxidant enzymes [26].
Different authors in the past examined the effects of
sleep apnea episodes on auditory sensitivity and the pos-
sible association between OSAS and hearing disorders [27,
28], analyzing mainly the auditory brainstem function
through ABR recording. However, to our knowledge, few
of them focused on the inner ear dysfunction and data
about TEOAEs and high frequencies (9–16 kHz) audiom-
etry are scarce.
From the analysis of our data it is well shown that OSAS
patients suffer of hearing impairment, particularly when we
compare those with moderate to severe OSAS with simple
snoring subjects (P\ 0.0001). In addition, a higher per-
centage (42 %) of tinnitus was found among individuals
with OSAS with respect to patients without OSAS (20 %)
with a peak (62.5 %) in case of severe OSAS (P = 0.024)
Fig. 1 Average multi-frequency audiometry thresholds levels in
patients with and without OSAS
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Fig. 2 TEOAEs in patients with and without OSAS: analysis of SNR
data
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and a tinnitus pitch recognized mainly in the frequency
range of 4–8 kHz (64.81 %). The study of audiometric
thresholds of the whole sample (Fig. 1), conducted with the
multi-frequency audiometry, evidenced superimposable
audiometric curves in patients with and without OSAS
when considering the frequency range from 0.25 to 3 kHz.
From the comparison of 4–16 kHz frequencies audiometric
values instead it was possible to evidence a progressive
lowering in hearing threshold, with a statistical significant
difference between severe and simple snoring patients for
3–16 kHz frequencies (P\ 0.01). This is in line with
Casale et al. data, who observed a significant difference
(P\ 0.01) in the 4 kHz auditory thresholds between
individuals with AHI[30 and subjects without OSAS [15].
Our findings are supported also by Kilic et al. who,
studying the high frequencies audiograms of 42 subjects
with chronic asthma, found lower PTA10–20 kHz values in
hypoxic and non-hypoxic asthma patients with respect to
healthy controls (P\ 0.05) [29].
The recording of TEOAEs revealed a low SNR for 3 and
4 kHz frequencies, with more than 50 % of patients with
values\6 (Fig. 2). Particularly, as confirmed by Casale
et al., a statistical significant difference was found between
simple snoring and severe OSAS subjects for 3 and 4 kHz
frequencies (P\ 0.05) [15]. She et al. assessing 28 patients
with OSAS before uvulopalatopharyngoplasty, observed a
low prevalence of TEOAE (64.3 %) and a reduced
0.5–8 kHz amplitude of DPOAE, with an improvement of
all variables studied after surgery [30]. Similar findings
were reported by Xu et al. in children affected by OSAS,
with a significant difference of DPOAE amplitude at
6–8 kHz between moderate to severe OSAS patients and
control group [31]. These data may reflect the particular
susceptibility of cochlear outer hair cells to insufficient
blood flow and the early involvement of the basal turn of
the cochlea [26].
Because of OSAS is a condition associated with an
enhanced oxidative stress status [32, 33], the mean ROS
levels of our cohort were evaluated with d-ROM test which
represents an overall estimation of oxidative stress
throughout the body. A significant difference between
mean ROS levels of patients with severe OSAS and simple
snoring subjects was evidenced (P = 0.004). On the con-
trary, other authors did not found an increased oxidative
stress with respect to controls [34, 35].
For example, Simiakakis et al. studying 42 patients with
AHI[15 and 24 controls (AHI\5) evidenced lower ROS
levels (404.3 ± 98.3 CARR U, P = 0.005) but also a
decreased antioxidant capacity (2057.2 ± 561.7 mmol/L,
P = 0.005) in patients with OSAS. However, they con-
cluded that factors like obesity or smoking can play a
confounding role in enhancing d-ROM levels and in
reducing antioxidant activity; additionally, hypoxia in
OSAS may act in inducing reduction of antioxidant
capacity through the dysregulation of genes involved in the
modulation of ROS or enzymes engaged in the production
of the antioxidant barriers [21].
An imbalanced oxidative stress can lead to microcircu-
latory dysfunction, as demonstrated by Patt et al. who
examined the endothelial function in OSAS patients free of
cardiovascular diseases. They evidenced increased perox-
ynitrite production in the microvascular walls of patients
with OSAS, indicating overproduction of NO and superox-
ide in the endothelial environment. The uptake of NO by
superoxide explains the decreased NO availability and the
consequent microcirculatory changes which resulted inde-
pendent of age, weight, or sex and reversible with treatment
[36]. Similar mechanisms could be responsible of a pro-
gressive impairment of inner earwhere theNOproduction by
cochlear vascular cells causes smooth muscle and pericyte
relaxation by the inhibition of voltage-gated calcium chan-
nels and the activation of ATP-sensitive K? channels in
endothelial and smooth muscle cells of the spiral modiolar
artery [37]. Thus the cochlear impairment and the associated
hearing loss could represent an early marker of microcircu-
latory dysfunction in individuals with OSAS.
The present study, examining the inner ear function of
patients with and without OSAS, underlines the key role of
chronic nocturnal intermittent hypoxia in the development
of auditory dysfunction and demonstrates a more marked
high-frequency hearing loss in case of severe OSAS
(P\ 0.05). We suggest that TEOAEs recording and multi-
frequency audiometry could represent helpful tools in
recognizing the early cochlear damage that characterizes
OSAS patients.
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